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Abstract
Background: The gp41 component of the Human Immunodeficiency Virus (HIV) envelope glycoprotein (Env)
contains a long cytoplasmic domain (CD) with multiple highly conserved tyrosine (Y) and dileucine (LL) motifs.
Studies suggest that the motifs distal to major endocytosis motif (Y712HRL), located at residues 712-715 of Env, may
contribute to Env functionality in the viral life cycle. In order to examine the biological contribution of these motifs
in the biosynthesis, transport, and function of Env, we constructed two panels of mutants in which the conserved
Y- and LL-motifs were sequentially substituted by alternative residues, either in the presence or absence of Y712.
Additional mutants targeting individual motifs were then constructed.
Results: All mutant Envs, when expressed in the absence of other viral proteins, maintained at least WT levels of
Env surface staining by multiple antibodies. The Y712 mutation (Y712C) contributed to at least a 4-fold increase in
surface expression for all mutants containing this change. Sequential mutagenesis of the Y- and LL-motifs resulted
in a generally progressive decrease in Env fusogenicity. However, additive mutation of dileucine and tyrosine
motifs beyond the tyrosine at residue 768 resulted in the most dramatic effects on Env incorporation into virions,
viral infectivity, and virus fusion with target cells.
Conclusions: From the studies reported here, we show that mutations of the Y- and LL-motifs, which effectively
eliminate the amphipathic nature of the lytic peptide 2 (LLP2) domain or disrupt YW and LL motifs in a region
spanning residues 795-803 (YWWNLLQYW), just C-terminal of LLP2, can dramatically interfere with biological
functions of HIV-1 Env and abrogate virus replication. Because these mutant proteins are expressed at the cell
surface, we conclude that tyrosine and di-leucine residues within the cytoplasmic domain of gp41 play critical roles
in HIV-1 replication that are distinct from that of targeting the plasma membrane.
Background
The envelope glycoprotein (Env) cytoplasmic domain
(CD) is a key determinant in the replication of Human
Immunodeficiency Virus type I (HIV-1) at two pivotal
steps: (i) at the point of viral assembly, where Env must
be incorporated into budding virions, and (ii)a tt h e
stage of viral entry into host target cells. The Env CD
has been shown through both genetic and biochemical
approaches to interact with domains of Gag during
assembly [1-3], interact with cellular components during
intracellular transport [4-7], modulate the fusogenicity
of the Env complex both in the cell and within the vir-
ion [4,8,9], and regulate the cell surface expression of
Env [10-13]. However, exactly which Env CD sequences
mediate these phenotypically important roles remains to
be elucidated.
Env, a type I transmembrane protein, is synthesized as
the precursor protein, gp160, on ribosomes associated
with the endoplasmic reticulum (ER) [14]. Upon oligo-
merization and correct folding of gp160 [14], the stable
complex is then transported from the ER to the trans
Golgi network, where Env is terminally glycosylated and
then processed into gp120, the receptor-binding surface
(SU) protein, and gp41, the trans-membrane (TM) com-
ponent, by a furin-like protease [14]. In the mature form
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mature Env complex, which facilitates viral entry into
host cells [15,16], is then transported to and expressed
on the cell surface, where either of two events may
occur: Env is either incorporated into budding virions or
it is rapidly internalized [10-13,17].
In the context of the mature virion, Env mediates vir-
ion attachment to the HIV-1 receptor, the CD4 mole-
cule, and its chemokine co-receptor, CXCR4 or CCR5,
and mediates fusion of the viral and cellular membranes
[2,3,9,10,18], thereby facilitating entry of the virus into
the host target cell. Viral infectivity depends on Env
incorporation into budding virions and the subsequent
entry into and infection of target cells.
Lentiviruses, such as HIV-1 and SIV, contain TM pro-
teins with unusually long CD of ~150 amino acids (aa),
in contrast to other retroviral TM CD, which are 20-40
aa long [14]. However, it remains unclear why these
long cytoplasmic tails have been conserved. Truncation
and elongation of the TM CD have been shown to alter
the functionality of Env in the viral life cycle. Trunca-
tion studies reveal that the CD is dispensable for Env-
mediated cell-cell fusion [3,19,20] and for SIV replica-
tion [21,22]. SIV growth in human cells selects for a
spontaneously truncated Env, which broadens the host
range of the virus [21,22]. However, the virus encoding
the truncated Env reverts back to wild type (WT) upon
inoculation into macaques [23]. This reversion back to
WT suggests that while this region is dispensable in
vitro, it plays an important role in vivo;a n dan u m b e r
of structural elements within the CD may contribute to
this in vivo function [24].
In HIV-1, truncation of the CD by as few as 20 amino
acids significantly reduced viral replication in most cell
types [2,19,20,25]. It is required in a cell-type dependent
manner for incorporation of Env into virions and for
generating a productive, transmissible infection in most
of the T cell lines tested [3]. Cell-type dependence may
be due to differences in expression and localization of
host factors [26], suggesting that gp41 CD interactions
with cellular proteins are important for efficient virus
assembly. Similarly, it appears necessary for this region
of Env to interact with the matrix (MA) domain of the
Gag polyprotein precursor for incorporation of full-
length proteins [1], which is supported by the fact that
mutations in the CD, which block Env incorporation,
can be rescued by amino acid changes in MA [3].
The HIV-1 gp41 CD contains several potential inter-
nalization and trafficking motifs, including four tyrosine
motifs at 712Yxx,7 6 8 Yxx,7 9 5 YW,a n d8 0 2 YW,a n ds i x
dileucine motifs at 774LL, 776LI, 784LL, 799LL, 814LL,
and 855LL, that have been conserved in the majority of
HIV-1 patient isolates. Both tyrosine-based (Yxx)a n d
d i l e u c i n e - b a s e d( L L )m o t ifs can play individual or
overlapping roles [27-29]. These overlapping roles are
modulated by different requirements for proximity to
trans-membrane domains and to the carboxy or amino
terminus [30]. Residues near the motif itself can either
strengthen or specialize the signal or the mediating
interaction [30]. Thus while these motifs have been
shown to facilitate endocytosis, basolateral targeting in
polarized cells, and targeting to specialized compart-
ments within the cells [30], dissecting out individual
functions for each motif is complex.
The membrane proximal Yxx motif has been estab-
lished as the major endocytosis signal for gp41
[11,12,31-33], which is suppressed in the presence of
Pr55gag [17]. The Y712 motif has been shown to direct
the basolateral targeting of Env and the polarized bud-
ding of HIV-1 [34,35] and to interact with the μ1a n d
μ2 chains of adaptin (AP) complexes [4,31,33]. Muta-
genesis of this motif in both the HIV and SIV Env CD
has consistently resulted in increased levels of cell sur-
face expression [7,11,13,32,35], although in one study
this resulted in decreased infectivity, entry, and poorly
replicating virus, independent of Env incorporation into
virions [36]. Further, a study in SIV demonstrated that
abrogation of the membrane proximal Yxx motif
through deletion of a highly conserved GY amino acid
pair yielded replication competent virus that was highly
attenuated in vivo [24].
The YW802 motif has been well studied and reported
to interact with TIP47, implicated in linking the Env-
Gag interaction [37], resulting in the retrograde trans-
port of Env from the endosome to the Golgi [5]. Abro-
gation or deletion of YW802 also resulted in decreased
Env incorporation, infectivity, and replication [3,38].
The C-terminal LL855 has also been shown to interact
with AP-1 and to regulate the subcellular localization of
Env [10], with varying reports regarding its role in the
endocytosis of Env [10,39]. The Y768xx motif, in addi-
tion to LL774,L I 776,a n dL L 784, overlaps with the inhibi-
tory sequence 2, is2, which has been described as
inhibiting the surface expression of Env [40], although
mutagenesis of Y768 alone did not result in a distinct
phenotype or loss of AP-2 μ chain binding by Env [31].
Interestingly, this tyrosine motif resembles the “three-
pin plug” tyrosine motif previously described for μ2
binding to the P-selectin protein [41], in that there is a
similar upstream leucine residue (LxxY768xxL) that
could also contribute to adaptin binding in the absence
of the tyrosine.
A number of the conserved motifs also overlap with
the amphipathic a-helical lentiviral lytic peptides LLP1
(aa 828-856) [42,43], LLP2 (aa 770-795) [44], and LLP3
(aa 789-815) [45]. This feature complicates mutational
analyses since LLP1 and LLP2 have been reported to
play a role in the fusion process [46]. Further
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novel finding that there is coupling of the fusion process
with virion maturation [47] and that the Env CD also
impedes the entry of immature virions into target cells
through its interaction with the immature Gag core
[46,48-50]. The complexity of these trafficking motifs,
located within close proximity to each other and physi-
cally overlapping with other functional domains, exem-
plifies the difficulty in dissecting out the roles of the
trafficking motifs conserved along the Env CD.
In order to better understand why HIV-1 has con-
served tyrosine and di-leucine motifs within the unu-
sually long CD of Env, we have employed a progressive
mutagenesis strategy to sequentially mutate all of the
conserved Y- and LL-based motifs in the gp41 CD, fol-
lowed by more targeted mutagenesis of individual
motifs. For each of these sequential mutants, we have
determined surface expression, fusogenicity, incorpora-
tion, and the ability to facilitate entry and infection into
target cells. Sequential mutagenesis generally resulted in
progressive impairment of Env fusogenicity, Env incor-
poration, viral infectivity, and viral entry, despite
efficient transport and expression of Env on the cell sur-
face. The most dramatic phenotype was observed fol-
lowing mutation of Y768, and adjacent dileucine motifs
within LLP2, which points to a critical role for the
amphipathic nature of thisr e g i o ni nm o d u l a t i n gE n v
function. This was confirmed by targeted mutagenesis,
which also identified a motif in LLP3 critical for virus
entry and replication.
Results
Generation of Env mutants
The unusually long CD of gp41 contains multiple Y-
and LL-motifs. In order to define the functional role
played by these motifs in the HIV-1 life cycle, a progres-
sive mutagenesis strategy was employed in which the Y-
and LL-based motifs were sequentially mutated along
the Env CD. Several of these motifs overlap the Rev
open reading frame, necessitating substitutions that
maintain Rev function. The mutants were classified
based on their location in the NL4-3 Env and are shown
in Figure 1. Site-directed mutagenesis was employed to
introduce the trafficking motif mutations into the env
NL4.3    ..YSLP.....LFSYHRLRDLLLIVTRIVELLGRRGWEALKYWWNLLQYW.......LL........LL
WT       ..Y........L..Y..L..LLLI......LL.........Y...LL.YW.......LL........LL
 A       ..Y........H..S......................................................
 B       ..Y........H..S..S..SHSN.............................................
 C       ..Y........H..S..S..SHSN......HQ.....................................
 D       ..Y........H..S..S..SHSN......HQ.........S...HQ.S....................
 E       ..Y........H..S..S..SHSN......HQ.........S...HQ.S........AA........AA
 Y       ..C..................................................................
YA       ..C........H..S......................................................
YB       ..C........H..S..S..SHSN.............................................
YC       ..C........H..S..S..SHSN......HQ.....................................
YD       ..C........H..S..S..SHSN......HQ.........S...HQ.S....................
YE       ..C........H..S..S..SHSN......HQ.........S...HQ.S........AA........AA
S1       ...........H.........................................................
S2       ..............S......................................................  
S3       ....................SHSN.............................................  
S4       ..............................HQ.....................................  
S5       .........................................SL..........................
S6       .............................................HQ......................
S7       ................................................SL...................
S8       .........................................................AA..........
S9       ...................................................................AA
LLP2
712 765   768  771  774  776            784                        795     799   802                 814                     855
HIV-1 ENV Cytoplasmic Domain
Figure 1 HIV-1 Env cytoplasmic domain Y- and LL-motif mutagenesis strategy. The key amino acids of the Y- and LL-motifs targeted for
mutagenesis are listed under the corresponding location in the sequence of NL4-3 envelope cytoplasmic domain. WT residues are indicated by
regular-faced type, and the residues in bold-faced type represent the mutations for each mutant. The glycoproteins are separated by those
containing the WT Y712 motif and by those containing the Y712C mutation.
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lized to create progressive mutants in the CD. Introduc-
tion of the L765H/Y768S mutations into the env
sequence generated mutant A. The subsequent addition
of L771S/LLLI774SHSN to mutant A results in mutant
B, the addition of LL784HQ to mutant B results in
mutant C, the additional changes of Y795S/LL799HQ/
Y802S to mutant C produce mutant D, and LL814AA/
LL855AA was combined with mutant D to create
mutant E. Introduction of the Y712C mutation to WT
and the Env mutants A, B, C, D, and E resulted in the
generation of the Y, YA, YB, YC, YD, and YE mutants.
The role of individual motifs was then probed by an
additional set of mutations (Figure 1). All Env CD
mutants were cloned into the Env expression vectors
pSRHS and pSRHS-EB, as well as the proviral vector
pNL4.3.
Envelope biosynthesis, processing, and stability
In order to investigate the effects of this mutagenesis on
the biosynthesis, processing, and stability of the glyco-
proteins, WT and mutant envelopes were expressed
from the SV40-based pSRHS vector, which also
expresses Rev and Tat. Env expression was under the
control of the SV40 late promoter and polyadenylation
signals were provided by the long terminal repeat (LTR)
of the Mason-Pfizer monkey virus [19,21]. The WT and
mutant glycoproteins were expressed in COS-1 cells,
which have been shown to facilitate high expression of
Env from pSRHS [19]. Two days after transfection, the
Env proteins were metabolically labeled for 30 min with
[
35S] and further chased for 4 h in complete unlabeled
media. Following lysis of the cells, the glycoproteins
within the cell lysates and supernatants were immuno-
precipitated with HIV-1 patient sera, resolved by SDS-
PAGE, and visualized by autoradiography [19,21].
Sequential mutagenesis of the Y- and LL-based motifs
in the CD mutants did not decrease the level of expres-
sion of gp160, or the processing of precursor to gp120
and gp41, indicating normal intracellular transport to
the trans-Golgi network, as seen in a pulse-chase experi-
ment in Figure 2A. Examination of the amount of gp120
shed into the supernatant also revealed that the muta-
genesis of these motifs did not alter the stability of
gp120, represented in Figure 2B. Similar results were
seen in pulse-chase experiments conducted with the
pSRHS-EB Env expression constructs (data not shown).
Effects of sequential mutagenesis in the cytoplasmic
domain of Env on cell-cell fusion
Because the Env trafficking motif mutants maintained
WT levels of biosynthesis, processing, and stability, we
wanted to screen the glycoproteins for functionality. In
order to measure Env-mediated cell-cell fusion, a luci-
ferase-based fusion assay was utilized. The Env expres-
sion vector containing WT and mutant env genes,
including both the rev and tat genes, was expressed in
COS-1 cells. Two days after transfection, the transiently
transfected COS-1 cells were co-cultured and mixed
with TZM-bl indicator cells, which contain an HIV-2
LTR driven luciferase gene and express the HIV-1
receptor, CD4, and coreceptors CCR5 and CXCR4.
Upon fusion of the cellular membranes of the Env
gp160
gp120
gp41
gp120
B
CELL
LYSATES
SUPER-
NATANTS
A NC WT A    B    C     D   E   Y   YA  YB  YC  YD  YE
Figure 2 Biosynthesis and processing of mutant glycoproteins.
COS-1 cells transiently transfected with the Env expression vector
pSRHS were metabolically labeled in a pulse, followed by a 4 h
chase and immunoprecipitated with anti-HIV-1 patient sera. The
locations of the Env precursor and the components of the mature
Env complex are indicated at the left of the gel. The pulse-chase
cell lysates of glycoproteins expressed from the pSRHS vector (A)
are shown in the gel at the top, and the corresponding gel for the
amount of gp120 shed into the supernatant (B), is shown in the gel
at the bottom.
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Figure 3 Env-mediated cell-cell fusion. COS-1 cells transiently
transfected with the Env expression vector were cultured for 24 h.
The COS-1 cells transiently expressing WT and mutant glycoproteins
were co-cultured with TZM-bl indicator cells. Following a 24 h
incubation, the co-culture of cells was lysed and measured for
luciferase activity. P values were calculated by using Tukey’s T-test
and a value <0.001 are shown with an asterisk. The data represents
results from three independent experiments conducted in triplicate.
In these assays WT fusion yielded an average of 4.7 × 10
5 DLU and
EBFP an average of 8.4 × 10
3 DLU. The error bars represent the
standard deviation of the means.
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which is also expressed from pSRHS-EB, activates the
HIV-2 LTR and drives luciferase production [51]. A
quantitative analysis of Envelope mediated cell-cell
fusion was measured for each of the mutants by calcu-
lating their relative luciferase enzyme activity compared
to WT. The relative luciferase activity for each of the
mutants was averaged from three independent experi-
ments performed in triplicate; these results are shown in
Figure 3. The low background resulting from the EBFP
control, expressed from the pEBFP-N1 construct lacking
the env, rev,a n dtat genes, was subtracted from the
experimental values to give a baseline for fusion activity.
In Figure 3, the Env mutants have been separated into
two series, those containing the WT Y712 motif and
those containing the Y712C mutation. Direct compari-
son of the two panels indicates that the Y712C mutation
did not affect the fusogenicity of the Env mutants in the
context of cell-cell fusion, with the Y mutant maintain-
ing 96% fusion activity compared to WT. Mutagenesis
of the first two pins (L765H and Y768S) in the three-
pin motif LxxY768xxL, which binds to AP2, at the N-ter-
minus of LLP2 resulted in 62% and 63% the fusogenicity
of WT for mutants A and YA, respectively. Subsequent
mutagenesis of the third pin (L771S) and the LL774LI776
motifs resulted in a significant decrease in fusion com-
pared to WT, with B and YB reducing fusogenicity to
41% and 35% of WT respectively. Fusion activity
decreased in the remaining mutants to approximately
30% that of WT, while mutant YE had a greater
decrease at 17% of WT. Thus, sequential mutagenesis of
the Y- and LL-based motifs within the long CD of HIV-
1 Env resulted in a progressive decrease of Env
mediated cell-cell fusion activity. These results show
that mutation of the Y- and LL-based motifs contained
within the Env CD can modulate fusion activity of the
Env glycoprotein.
Effects of mutagenesis in the cytoplasmic domain on Env
cell surface expression
Because sequential mutagenesis of the trafficking motifs
within the CD resulted in a progressive decrease in Env
fusion activity, we wanted to establish whether this
resulted from an altered transport to and expression on
the cell surface. COS-1 cells expressing the WT and
mutant envelopes were stained with each of three
monoclonal antibodies (mAb): 902, which recognizes a
linear epitope on the gp120 V3 loop [52,53], b12, which
recognizes an epitope that overlaps the CD4 binding site
[54,55], and 2G12, which recognizes a complex of car-
bohydrates on the surface of gp120 [56]. The first two
were directly conjugated to AlexaFluor
®647, while 2G12
was detected using Alexa647 labeled Goat anti-human
IgG (H+L). Following immunostaining, the cells were
subjected to flow cytometry analysis. EBFP expression
from the Env expression vector served as the experi-
mental transfection control. The results from the flow
cytometry analysis are shown in Figure 4. Once again,
the samples have been separated into two series: those
containing the WT Y712 motif and those containing the
Y712C mutation. The MFI Index value was calculated
for each of the samples. The results indicate that all of
the Env CD mutants maintained at least WT levels of
surface expression, while introduction of the Y712C
mutation into the CD resulted in an increase in glyco-
protein cell surface expression, following immunostain-
ing with all three antibodies. In Figure 4A, the flow
cytometry dot plots of mAb 902 stained cells reveal a
distinct shift in the staining pattern between the WT
Y712 panels and the Y712C panels, with a greater pro-
portion of the cells staining and with higher intensity in
the latter, consistent with increased levels of surface
expression. The corresponding MFI Index values are
shown in Figure 4B. The MFI Index values for the WT
Y712 panel of mutants were similar to WT Env levels
with A at 101%, B at 195%, C at 125%, D at 120%, and
E at 136% that of WT. By inserting the Y712C mutation
into WT Env, the MFI Index value of the Y mutant
increased to 447% of WT. This increase was reflected in
the MFI Index values of the other mutants containing
the Y712C, including YA at 563%, YB at 396%, YC at
563%, YD at 409%, and YE at 194%.
We confirmed the increased surface expression with
the 2 additional monoclonal antibodies. The results for
immunostaining with mAb b12 are shown in Figure 4C
and those for mAb 2G12 in Figure 4D. The staining pat-
terns for both antibodies are similar to that observed
with mAb 902, with a majority of the Y712WT mutant-
expressing cells exhibiting MFI indices similar to WT
Env, although for 2G12 a 3-4-fold increase in surface
s t a i n i n gw a so b s e r v e df o rm u t a n t sB - E .A sw i t h9 0 2 ,a
majority of the cells expressing the Y712C-containing
mutants exhibited much higher levels of surface staining
with b12 and 2G12, although the absolute increase dif-
fered (approximately 8 and 10-fold for Y, respectively).
In each case, cells expressing the YE mutant showed the
smallest increase in Env surface expression of the
Y712C-containing mutants relative to WT.
Env CD mutants exhibit a defect in virus entry and virus-
cell fusion
Because the levels of surface expression of the Env CD
mutants did not correspond to the observed defects in
cell-cell fusion, we examined the Env mutants, in the
context of pSG3Δenv pseudotyped virus, for their capa-
city to mediate virus entry and virus-cell fusion.
A luciferase-based single round virus entry assay was
conducted, utilizing the same target cell fusion system
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virus (normalized for p24), produced in COS-1 cells,
were used to infect TZM-bl indicator cells. The cells
were measured for luciferase activity at 48 h post-infec-
tion. The SG3Δenv virus was used as the background
control. The results indicate that the sequential muta-
genesis of the Env CD trafficking motifs resulted in
much more pronounced defective phenotypes in the
context of pseudotyped virus as shown in Figure 5A. In
contrast to the cell-cell fusion results, where the maxi-
mum decrease observed for mutant E was 70%, infectiv-
ity of virus pseudotyped by this Env was reduced 99%.
Even mutant B, in which just the Y768 motif and two
adjacent dileucine motifs are mutated, exhibited only
16% the virus entry activity of WT Env. While the
Y712C substitution in mutant Y had little effect on cell-
cell fusion, the infectivity of viruses pseudotyped with
this Env was 47% that of WT, and the remaining
Y712C-containing mutants were reduced in virus entry
by more than 94% compared to WT.
In order to further define the defect in entry, we uti-
lized the b-lactamase virus-cell fusion assay described
previously [57-60]. For this assay, pNL4-3 proviral
clones were co-transfected with a b-lactamase-Vpr
fusion protein (BlaM-Vpr) expression vector, and the
released virus was used to infect TZM-bl cells as
described in Materials and Methods. The extent of
virus-cell fusion, as assessed by intracellular b-lactamase
activity, is shown in Figure 5B. The results of this assay
were similar to those observed in the virus entry assay
(Figure 5A), with only mutants A, Y and YA exhibiting
low levels of b-lactamase activity, 14-17% that of WT.
Figure 4 Cell surface expression of envelope glycoproteins. (A) COS-1 cells transiently transfected with each of the pSRHS-EB Env expression
vectors were immunostained with Alexa*647-conjugated anti-gp120 mAb 902. The dot plot panels are separated into two series for analysis: (1)
those containing the WT Y712 motif in the top row, and (2) those containing the Y712C motif in the bottom row. (B) The quantified surface
expression levels of the Env glycoproteins are shown as the relative mean fluorescence intensity (MFI) Index (MFI x% of cells double positive for
EBFP and Alexa*647). Additional cells were stained with Alexa*647-conjugated anti-gp120 mAb b12 (C) and anti-gp120 mAb 2G12 + Alexa*647-
Goat anti-hu IgG (H+L) (D). The error bars represent the standard deviation of the means.
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To establish whether a defect in Env incorporation into
virions contributed to the infectivity impairment of the
Env CD mutants, we measured virus-associated gp120
and gp41 glycoprotein. The CD mutant viruses were
recovered from provirus transfected 293T cells, pelleted
through a 25% sucrose cushion, and then subjected to
p24 and gp120 ELISAs and gp41 western blotting. The
ratios of gp120/p24 and gp41/p24 were calculated for
each virus to measure Env incorporation into virions, and
are shown in Figure 6 as the percentage of WT. Mutant
A incorporated near WT levels of both gp120 and gp41,
but the levels of virus-associated glycoprotein rapidly
decreased, with mutants B through E incorporating 24-
38% the amount of gp120 and 5-22% gp41 compared to
WT. The Y712C mutation reduced the level of gp120
and gp41 incorporation to 49% and 73% that of WT,
respectively. Although, the level of virus-associated gp41
was increased in mutant YA (154% of WT), such muta-
tions appeared to impair stability of Env complexes, since
gp120 incorporation was only 73% of WT. The addition
of the Y712C mutation facilitated gp41 incorporation in
mutant YB and YC, compared to their non-Y712C coun-
terparts, while mutants YD and YE showed similar gp41
levels to their non-Y712 counterparts.
Effects of individual tyrosine and di-leucine mutants in
the Env cytoplasmic domain
Because mutations beyond B or YB exhibited only lim-
ited additional phenotypic defectiveness, we performed
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Figure 5 I n f e c t i v i t ya n de n t r yo fE n vc y t o p l a s m i cd o m a i n
mutants. (A) Single round infectivity. Env-pseudotyped SG3ΔEnv
viruses produced in 293T cells and p24-normalized, were used to
infect TZM-bl indicator cells. After a 48 h incubation, the cell
mixtures were lysed and luciferase activity was assayed. In this assay
infection with virus pseudotyped with WT Env yielded 2.7 × 10
5
DLU and ΔEnv virions an average of 1.65 × 10
4 DLU (B) Virus-cell
fusion assay. Env CD mutants in NL4-3, pseudotyped with pCMV-
BlaM-Vpr, were produced in 293T cells and subjected to gradient
ultracentrifugation. Resuspended viral pellets were then normalized
using p24 ELISA assays and used to infect TZM-bl indicator cells.
The CCF2-AM fluorescent dye was loaded into the cells and
incubated for 16 h at room temperature. The data represents results
from three independent experiments conducted in triplicate. The
error bars represent the standard deviation of the means. WT virus
induced blue fluorescence in 5.48% of the 25,000 cells analyzed, a
mock infected background of 0.46% blue cells was subtracted from
all values.
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Figure 6 Incorporation of Env glycoproteins into virions. NL4-3
viruses containing the WT and mutant Env proteins were produced
in 293T cells and pelleted through a 25% sucrose cushion.
Resuspended viral pellets were then subjected to p24 ELISAs, gp120
ELISAs, and gp41 western blotting. Incorporation of Env into virions
is calculated as the ratio of gp120/p24 (A) and gp41/p24 (B) and
shown as the percentage of WT. The data represents results from
three independent experiments conducted in triplicate. The error
bars represent the standard deviation of the means.
Bhakta et al. Retrovirology 2011, 8:37
http://www.retrovirology.com/content/8/1/37
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whether they could significantly influence the functions
of HIV-1 Env. As shown in Figure 1, nine additional sin-
gle-motif mutants were constructed. Mutations in S1
(L765H), S2 (Y768S), S3 (LLLI774SHSN), and S4
(LL784HQ) are located in the N-terminus (S1, S2), mid-
dle (S3) and C-terminus (S4) of the LLP2 motif.
Mutants S5 (YW795SL), S6 (LL799HQ), S7 (YW802SL),
S8 (LL814AA), and S9 (LL855AA) target the other Y-
and LL-motifs downstream of the “three-pin” motif.
Cell-cell fusion and single-round infection mediated by
these Env mutants were measured and compared to
WT using the same methods as described for the pro-
gressive mutants.
As shown in Figure 7A, each single motif is required
for WT level of Env-mediated cell-cell fusion; however,
Env fusogenicity is not dominated by a particular single
motif. Most of the single-motif mutants retained 75% to
85% of WT cell-cell fusion. The integrity of the LLP2
motif appeared most important for Env fusogenicity
since mutants S2 (Y768S) and S3 (LLLI774SHSN)
retained the lowest level of cell-cell fusogenicity, 64.7%
and 67.8% of WT, respectively.
Consistent with its function in Env-mediated cell-cell
fusion, the LLP2 motif is also very important for virus
entry (Figure 7B). The loss of hydrophobicity in mutants
S1 (L765H), S3 (LLLI774SHSN), and S4 (LL784HQ) sig-
nificantly reduced the single-round viral infection to
66.5%, 16.6%, and 59.2% of WT. Meanwhile, the mutant
S2 (Y768S) exhibited only 45% WT efficiency of virus
entry. Other motifs, including YW795, LL799, and
YW802, appeared critical for virus entry as well. Mutants
S5 (YW795SL), S6 (LL799HQ), and S7 (YW802SL)
retained only 19%-32.9% WT efficiency in the single-
round infection assay. Interestingly, the motifs LL814
and LL855 did not appear to be necessary for virus entry,
even though they reduced Env-mediated cell-cell fusion
to a small extent. These data indicate that a majority of
the Y- and LL-motifs in the Env CD contribute to
decreases in viral infectivity as mutations accumulate.
Effects of individual motif mutations on virus replication
in T cells
In order to examine the influence of the Env CD
mutants on virus replication, we measured the replica-
tion kinetics of these mutants over a period of 12 days
in both the H9 and CEM T cell lines by a reverse tran-
scriptase assay. NL4-3 proviral constructs were trans-
fected into 293T cells, supernatant virus was titered on
TZM-bl cells, then CEM or H9 cells were infected with
an equal MOI (0.05). As shown in Figure 8A, in CEM
cells, single-motif mutants, S4 (LL784HQ) and S8
(LL814AA) showed similar replication capacities in H9
cells, with an initial replication rate comparable to WT.
Mutants Y and A, as might be predicted from single
round infections, demonstrated delayed replication
kinetics, with peak RT values equivalent to, but 2 days
after, WT. The additional mutation of the hydrophobic
core of LLP2 in mutant B completely abrogated viral
replication, with RT values dropping progressively over
the course of the experiment, indicative of the infection
of cells by the initial inoculum but then loss of RT pro-
duction because the virus is unable to assemble infec-
tious virus in T cells. The fact that mutant S3
(LLLI774SHSN) exhibits a significant but incomplete
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Figure 7 Single-motif mutants in the Env CD. (A) Cell-cell fusion
mediated by Env carrying the single-motif mutants. (B) Single-round
infection of viruses SG3Δenv, which were pseudotyped with single-
motif Env mutants, in TZM-bl indicator cells. The error bars
represent the standard deviation of the means.
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these mutations with mutant A, as in mutant B, is
highly detrimental to the virus. Three mutants S5
(YW795SL), S6 (LL799HQ), and S7 (YW802SL) demon-
strated a 6-8 day-delay before virus replication acceler-
ated - and for S5 and S6 the peak of virus remained
approximately 10-fold below that of WT.
Similar patterns of replication were observed in H9
cells (Figure 8B), except that mutants S3, S5, S6 and S7
exhibited much greater defects in replication, with peak
RT values approximately 100-fold less than that of WT.
Thus, in these cells, simply mutating the hydrophobic
core of LLP2 (mutant S3) or any of the individual tyro-
sine or di-leucine motifs in LLP3 effectively abrogates
virus infectivity.
Discussion
The objective of this study was to investigate the role of
the highly conserved Y- and LL-based motifs within the
gp41 cytoplasmic domain (CD) in the HIV-1 life cycle.
To this end, we have employed a progressive mutagen-
esis strategy, in which all of these motifs were sequen-
tially mutated throughout the CD, and have followed
this up with mutagenesis of individual motifs to probe
additional function. Previous studies have attempted to
study the role of the CD in the context of chimeric pro-
teins [4,10,11,39,40], while others have truncated the CD
in order to determine the affects on Env functionality
[19,61-64]. However, while such an approach allows
removal of all currently known trafficking motifs in the
CD, there appears to be a functional dependence
between the gp41 CD and its ectodomain, as well as a
conformational dependence of gp120 on the Env CD
[65]. This makes studying Env in the context of the full-
length CD even more crucial. Truncation of the CD
results in an increased susceptibility to neutralization by
antibodies, likely due to a more open trimer conforma-
tion [55,66], and an increase in viral entry by non-repli-
cating immature virions [47,50]. Similar studies also
demonstrated that production of fully infectious virus
requires the long CD [26].
Env glycoprotein biosynthesis, processing, stability,
and transport to the Golgi (based on cleavage of gp160
to gp120 and gp41) were unaffected by the mutation of
trafficking motifs. These motifs also appear, for the
most part, to be dispensable for transport of Env to the
cell surface. The Y712 motif, however, appears to be
important for regulating the cell surface expression of
the HIV-1 Env, as evidenced by a minimum 4-fold
increase in surface expression of the Y (Y712C) mutant.
Because the b12 mAb binds to an epitope that overlaps
with the CD4-binding site on gp120, and because we
were concerned with the structural dependence of
gp120 on the gp41 CD, we performed surface
immunostaining with three monoclonal antibodies,
including mAb 902 and mAb 2G12, which bind a linear
protein epitope and a complex carbohydrate epitope,
respectively. All three mAb showed an increase in sur-
face expression of the Y-mutants compared to the WT
Y712 mutant panel, and a slight decrease in YE com-
pared to the rest of the Y-mutants. All of the mutants
maintained at least WT levels of surface expression in
COS-1 cells, while all of the Y-mutants exhibited an
increase in surface expression. This is consistent with
previous studies of the membrane proximal Yxx motif
in Env of both HIV and SIV [7,10,11,13,32,35].
A consistently lower level of surface staining relative
to the other Y-mutants was observed for the YE mutant,
even though this still exceeded that of WT Env for each
mAb. In contrast, this was not observed for the E
mutant, which exhibited surface staining levels equiva-
l e n tt ot h eB ,C ,a n dDm u t a n t s .B e c a u s eY El a c k sa n y
of the conserved Y- and LL-based trafficking motifs, and
so is unlikely to be more efficiently endocytosed, the
reduced surface staining is most easily explained by less
efficient transport of this mutant to the PM, perhaps
because in the absence of Y712 necessary adaptin inter-
actions are impaired.
Despite an increase in surface expression in the
Y712C-containing mutants, there was a progressive
decrease in Env fusogenicity from WT through C, after
which Env fusogenicity stabilized (summarized in Table
1). Similar results were observed with the Y-mutants,
although the mutant YE again was the most defective.
Thus, changes in these tyrosine and dileucine motifs
within the cytoplasmic domain are capable of inducing
phenotypic effects on an event that is commonly asso-
ciated with the ectodomain of Env (receptor and co-
receptor binding, 6-helix bundle formation). The motifs
mutated in A, B, and C are also of interest because they
overlap with the LLP2 motif (aa 765-788; see Figure 1)
in the NL4-3 gp41 CD, which has been proposed to
play a role in fusion [46,67]. Indeed, Lu et al., [46]
showed that at sub-optimal temperatures (31.5°C), anti-
bodies to this region could bind to the interface of fus-
ing cells and inhibit fusion. They proposed that,
following formation of the gp41 HR1/HR2 6-helix bun-
dle, the LLP2 peptide region is transiently exposed and
modulates fusion by interacting with this helical com-
plex. Consistent with this model, it is of interest that
the reduction in fusion we observed for the CD mutants
described here is maximal in mutant C (or YC), in
which 7/9 hydrophobic residues within LLP2 are
mutated and where the amphipathic nature of this
region has been completely abrogated.
The effect of the CD mutations on viral infectivity in
TZM-bl cells was much more pronounced than on cell-
cell fusion (summarized in Table 1). In assays of Env
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Page 9 of 17Figure 8 Replication in CEM (A) and H9 (B) cells. Viruses were generated by transfecting 293T cells with proviral DNAs. T cell lines were
infected with an M.O.I. of 0.05. The supernatants were collected at day 2, 4, 6, 8, 10, and 12, then subjected to a reverse transcriptase assay to
quantitate the amount of virions released at each time point.
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tivity were observed for all of the mutants. The A and Y
mutants retained approximately 50% infectivity in pseu-
dotyped virus assays, but the remaining mutants exhib-
ited less than 20% (16-1%) that of WT. The defective
stage in virus entry appeared to be at the level of virus-
cell fusion, since the results of BLAM assays closely par-
alleled the infectivity results observed, in that only A, Y,
and YA exhibited any virus-cell fusion and only at a
level of approximately 20% that of WT.
It seems likely that the defects in virus infectivity
represent the sum of defects in Env fusion and reduced
levels of Env incorporation into virions (Table 1). Env
incorporation decreased as more motifs were mutated,
with the greatest drop being observed between mutants
A and B (and in parallel between YA and YB). This is
again consistent with a role for the hydrophobic resi-
dues within LLP2 region of the CD, since in mutants B
and YB all of the hydrophobic residues in the N-term-
inal half of this region have been mutated to polar
residues.
The Y mutant virions also showed reduced levels of
Env incorporation, similar to that described in previous
studies [7,36,38]. This result seems paradoxical to our
observation of increased levels of Env at the cell surface,
w h i c hi sw h e r ev i r u sb u d s[ 6 8 ] .T h eb a s i sf o rr e d u c e d
levels of Env incorporation are at present unclear,
although it may reflect altered intracellular trafficking of
Env and an inability of Env and Gag to be directed to a
common site for assembly. Env clearly has the capacity
to redirect where virus assembly occurs in the cell. In
polarized epithelial cells, Env directs budding to the
basolateral membrane and in CD4 T cells to a single
pole of the cell [34,35,69,70]. Mutation of the major
endocytosis motif at Y712 has been shown to disrupt
polarized budding in both systems [34,35,70]. The loss
of additional tyrosine and di-leucine motifs in mutants
B-E (and YB-YE) could alter potential interactions of
LLP2 with LLP1 and the membrane [71], which might
further reduce the potential for co-localization of Env
and Gag, and explain the observed reduction in
incorporation.
Studies on single-motif mutants unraveled important
information hidden in the approach of cumulative muta-
genesis. An analysis of Env-mediated cell-cell fusion
showed that a majority of the Y- and LL-motifs in the
CD, when mutated individually, had only a limited effect
on this function. From the observed decrease in cell-cell
f u s i o nw i t hm u t a n t sAa n dB ,a sw e l la sY Aa n dY B ,i t
appears that combinations of these changes can result in
a more pronounced phenotype. This suggests that the
single motifs may together contribute to form a func-
tional structure, which is critical to HIV-1 Env-mediated
cell-cell fusion.
In contrast to cell-cell fusion, virus replication is
clearly impacted by some dominant single motifs. Three
of these motifs (Y768XXL, L774LLI, and L784L) main-
tain the hydrophobicity of the Env CD, specifically in
the LLP2 region, which is critically important for repli-
cation in T-cells. Whether mutation of this region pre-
vents a translocation of LLP2 across the membrane as
suggested by Lu et al. [46], or whether it prevents the
region from mediating close membrane proximity of the
Env CD, or interactions with other regions of the CD is
not clear. Additional studies to define the exact mechan-
ism of LLP2 function during virus replication are clearly
warranted.
A second region of clustered tyrosine and di-leucine
motifs is just C-terminal of the LLP2 region in LLP3.
Mutation of either YW motif (mutant S5 and S7) or the
LL motif (mutant S6) in this nine amino acid region
(YWWNLLQYW) had a very significant impact on
HIV-1 replication in T cells. This is consistent with pre-
vious results from Murakami and Freed (ref 2), who
Table 1 Summary of the Functional Properties of HIV-1 Env Mutants
Env
Mutants
Cell-Cell
Fusion (%)
Surface Expression
(mAb 902) (%)
Infectivity
(pseudotyped) (%)
Virus-cell
Fusion (%)
gp41
Incorporation (%)
WT 100 100 100 100 100
A 62 101 57 17 101
B 41 195 16 0 8
C 30 125 13 0 5
D 31 120 4 17 9
E 30 136 1 0 22
Y 96 447 47 0 73
YA 62 563 6 14 154
YB 35 396 6 0 39
YC 30 563 5 0 56
YD 29 495 2 0 9
YE 17 194 1 0 17
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also abrogated infectivity of HIV-1. Additional studies
have focused on the YW802 motif, which has been pos-
tulated to interact with the cellular trafficking protein
TIP47 in retrograde transport of Env from the endo-
some to the Golgi [5]. Mutation of the motif in Env or
silencing of TIP47 expression resulted in reduced Env
incorporation and virus infectivity [5,37]. In the studies
presented here, although we did not observe any addi-
tional reduction in Env incorporation following muta-
genesis of YW802 in mutant D, mutant S7 did exhibit
delayed replication kinetics in CEM cells and very lim-
ited replication in H9 cells compared to WT, consistent
with these previous studies. Nevertheless, it is clear that
this entire nine amino acid region, not just YW802 is
important for HIV-1 replication. Interestingly, only a
limited effect of the S5-S7 mutations was observed in
single round infections, suggesting that the constraints
on Env-Gag interactions in 293T cells, where virus for
these assays are produced, are less stringent than that in
T-cells.
Overall, these studies point to two regions in the HIV-
1 Env CD in which tyrosine and di-leucine motifs play
critical roles in the biological function of the protein
that are distinct from that of intracellular targeting of
Env from the endoplasmic reticulum to the plasma
membrane, thereby raising the possibility of therapeuti-
cally targeting these sequences in the future.
Conclusions
From the studies reported here, we show that sequential
mutagenesis of the Y- and LL-based motifs located
within the CD of HIV-1 gp41 had a profound effect on
Env function and demonstrates a critical role for hydro-
phobic residues in this region of the CD. This was evi-
dent in decreased Env-mediated cell-cell fusion, Env
incorporation into virions, viral entry into target cells,
and virus replication in T-cells. Env transport to the
plasma membrane occurred in the absence of all of the
conserved Y and LL motifs in the CD, arguing against a
critical role for them in outward transport of the pro-
tein. Plasma membrane location alone was clearly not
sufficient for efficient assembly of Env into virions, since
a majority of the mutants exhibited reduced levels of
Env incorporation and this, coupled with decreased
fusogenicity of Env, resulted in them being non-infec-
tious. The greatest phenotypic effects were linked to
multiple changes in the LLP2 region of the CD and a
region just C-terminal to this domain, which includes
two YW motifs and a dileucine motif. Additional experi-
ments will be required to determine whether the pheno-
typic defect resulting from changes in LLP2 reflects a
distinct role for this region in late stages of Env-induced
cell fusion, an alteration in CD-membrane interactions,
or changes in protein-protein interactions within or
between gp41 monomers necessary for the fusion pro-
cess. Similarly, further analysis of the down-stream
region, which has been implicated in binding the cellular
protein TIP47, is clearly warranted. Overall, these stu-
dies highlight two regions in the HIV-1 Env CD in
which tyrosine and di-leucine motifs play critical roles
in the biological function of the protein and where
changes in the context of the full-length domain have
dramatic effects on virus replicative capacity.
Methods
Cell lines and culture
COS-1 and 293T cells were obtained from the American
Type Culture Collection (Manassas, Va.), and TZM-bl
were obtained through the NIH AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID,
NIH: TZM-bl from Dr. John C. Kappes, Dr. Xiaoyun
Wu and Tranzyme Inc. [51,72]. Cells were maintained
in complete Dulbecco’s modified Eagle’sm e d i u m
(DMEM) supplemented with 10% fetal bovine serum
(HyClone Laboratories, Logan, UT), and 100 U/ml peni-
cillin G sodium, and 100 μg/ml streptomycin sulfate
(Gibco BRL, Rockville, MD), at 37°C and 5% CO2.A l l
transfections were performed using the Fugene 6
(Roche, Indianapolis, IN) protocol at ~70% confluency
of cells. All infections were conducted in DMEM con-
taining 1% FBS and 80 μg/ml DEAE-dextran.
Antibodies
The following reagents were obtained through the NIH
AIDS Research and Reference Reagent Program, Divi-
sion of AIDS, NIAID, NIH: HIV-1 gp120 Monoclonal
Antibody (IgG1 b12) from Dr. Dennis Burton and Car-
los Barbas [55,73-75], Hybridoma 902 (anti-gp120) from
Dr. Bruce Chesebro [52,76], HIV-1 gp120 Monoclonal
Antibody (2G12) from Dr. Herman Katinger [56,77],
HIV-1 p24 Monoclonal Antibody (183-H12-5C) from
Dr. Bruce Chesebro and Kathy Wehrly [53,78,79], and
HIV-IG from NABI and NHLBI. The HIV-1 patient sera
were obtained through the Emory CFAR Clinical Core.
The horseradish peroxidase conjugated goat anti-human
(heavy and light chains) mAb and the sheep anti-HIV-1
gp120 Polyclonal Antibody were purchased from Pierce
(Rockford, IL) and Cliniqa Corp (San Marcos, CA),
respectively. The Anti-HIV-1 gp120 D7324 mAb was
purchased from Aalto Bio Reagents Ltd (Dublin, IE).
AlexaFluor
®647 Goat anti-human IgG (Heavy and Long
Chain) was purchased from Invitrogen (Carlsbad, CA).
Glycoprotein and proviral expression constructs
The HIV-1 Env CD trafficking motif mutants were gen-
erated by employing either a Quickchange PCR muta-
genesis strategy (Stratagene, La Jolla, CA) or a multi-
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High Fidelity PCR System (Roche, Indianapolis, IN). The
resulting Env CD clones are referred to as follows: WT,
Y, A, B, C, D, E, YA, YB, YC, YD, and YE. The second
open reading frame (ORF) of tat, which overlaps with
the gp41 CD between the motifs at 712 and 768, is
unaffected by the substitutions made in these Env con-
structs. Because rev contains a second ORF that overlaps
with seven of the ten trafficking motifs within the Env
CD, the mutagenesis strategy employed focused on
maintaining the integrity of rev while mutating out the
Y and LL motifs within Env (Figure 1). The following
primers were used for mutagenesis:
Y712CFP - 5’GGCAGGGATGTTCACCATTATCG3’,
Y712CRP - 5’CGATAATGGTGAACATCCCTGC-
CTAACTC3’,
LY768HSFP - 5’GCCTGTGCCACTTCAGCTCCC-
ACCGC3’,
LY768HSRP - 5’GCGGTGGGAGCTGAAGTGGCA-
CAGGC3’,
L771/LLLI774SHSSFP - 5’GCTCCCACCGCTCGA-
AAGACTCACACTCGAATGTAACGAGG3’,
L771/LLLI774SHSSRP - 5’CCTCGTTACATTCGA-
GTGTGAGTCTTTCGAGCGGTGGGAGC3’,
LL784HQFP - 5’CGAGGATTGTGGAACTTCTGGG-
ACGCAGGGGG3’,
LL784HQRP - 5’CCCCCTGCGTCCCAGAAGTTC-
CACA-ATCCTCG3’,
Y795S/LL799HQ/Y802SFP - 5’GGAAGCCCTCAAA-
CTTGGTGGAATCACCAACAGTCTTGGAGTCAG-
G3’,
Y795S/LL799HQ/Y802SRP - 5’CCTGACTCCAAGAC-
TGTTGGTGATTCCACCAAGATTTGAGGGCTTCC3’,
LL814AAFP - 5’GC TGTTAACGCGGCCAATGC-
CAATGCCACAGC3’,
LL814AARP - 5’GGCATTGGCCGCGT TAACAGC-
ACTATTC3’,
LL855AAFP - 5’GGGCTTGGAAAGGATTGCGGC-
ATAAGATGGG3’,
LL855ARP - 5’CCCATCTTATGCCGCAATCCTTT-
CCAAGCCC3’
All Env CD mutants were created in or from pSPEX-
NL, a pSP-based vector (Promega, Madison, WI) con-
taining the EcoRI-XhoI sequences of HIV-1 NL4-3,
including the full-length cytoplasmic tail. Subsequent to
verification in pSPEX, the mutant PCR fragments were
subcloned at the unique sites NheIt oXhoIf r o mt h e
pSPEX shuttle vector to the mammalian expression vec-
tor pSRH, a simian virus 40 late-promoter-based expres-
sion vector containing the Mason-Pfizer Monkey Virus
constitutive transport element, to create the pSRHS con-
struct, which expresses a full-length Env from NL4-3.
The HIV-1 Env expression vector also encodes the tat
and rev genes from NL4.3 [8].
To measure the surface expression of the mutant Env
glycoproteins, an EBFP expression cassette was cloned
into the pSRHS vectors at the unique restriction sites
NheI and BlpI to create the pSRHS-EB vectors. The
EBFP cassette was excised from the previously described
vector [80]. For use in single-round infectivity and Env
incorporation assays, the mutant Envs were also cloned
into the proviral vector pNL4-3 via the unique sites
NheIa n dBlpI. All mutations were confirmed by DNA
sequencing and by using primers that flank the Env CD.
Glycoprotein expression and immunoprecipitation
Env trafficking motif mutants in pSRHS expression vec-
tors were transfected into COS-1 cells (2.5 × 10
5)
seeded in 6-well plates. To verify protein expression,
processing, and stability, the transfected cells were meta-
bolically labeled 36-48 hours posttransfection. The
transfected cells were starved for 15 min in methionine-
free and cysteine-free DMEM (Gibco-BRL, Rockville,
MD) and pulse-labeled for 30 min in the same medium
supplemented with [
35S]Methionine and [
35S]Cysteine
(125 μCi/well) protein-labeling mix (Perkin-Elmer NEN,
Boston, MA). The labeled cells were then chased for 4 h
in unlabeled complete DMEM. The chase supernatants
were removed and filtered through a 0.45 μmm e m -
brane to remove cellular debris. Cell lysates were pre-
pared on ice by addition of 0.5 ml ice-cold lysis buffer
(1% Triton X-100, 50 mM NaCl in 25 mM Tris-HCl
[pH 8.0]), and nuclei were removed from lysates by cen-
trifugation at 13,200 rpm for 10 min at 4°C in a micro-
centrifuge (Beckman, Palo Alto, CA). HIV-1 Env
proteins were immunoprecipitated from cell lysates and
supernatants by incubating at 4°C with HIV-1 patient
sera. Immunoprecipitated proteins were then precipi-
tated with formalin-fixed Staphylococcus aureus (protein
A) and washed three times in lysis buffer containing
0.1% sodium dodecyl sulfate (SDS). The labeled proteins
were resolved by 10% SDS-PAGE, visualized by autora-
diography, and quantified using a Cyclone phosphorima-
ging system (Packard, Meridian, CT) as previously
described [81].
Cell-cell fusion assay
COS-1 cells (2.5 × 10
5) were seeded in 6-well plates,
transfected with the pSRHS-EB Env expression vectors
at ~70% confluency, resuspended by trypsinization, and
co-cultured with TZM-bl cells at a ratio of 1:5. The co-
cultures of cells were incubated for 24 h and then lysed
in the luciferase reporter buffer (Promega, Madison,
WI). The cells were twice subjected to freezing for 1
hour and then thawing for 20 min, followed by centrifu-
gation (Beckman, Palo Alto, CA) of the lysates at 13,200
rpm for 10 min to remove any cellular debris. Each cell
lysate (40 μl) was added to a well in a 96-well plate, and
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(Promega, Madison, WI). Light emission was then mea-
sured using a Synergy multi-detector microplate reader
(Biotek, Vinooski, VT) as previously described [59].
Cell surface expression of Env glycoprotein
Surface expression of WT and mutant Env glycoproteins
was measured using Flow cytometry in both a primary
and secondary antibody (Ab) detection system. Env sur-
face expression was measured by the human anti-gp120
mAb b12 and the mouse anti-gp120 mAb 902 each con-
jugated to AlexaFluor
®647 (Invitrogen, Carlsbad, CA) in
a primary detection system. The human 2G12 mAb was
used in conjunction with the AlexaFluor
®647 Goat anti-
human IgG (H+L) to measure Env surface expression in
a secondary Ab detection system. The Env proteins
were expressed from the pSRHS-EB vector. EBFP
expression served as a positive transfection control for
these experiments. COS-1 cells were transiently trans-
fected with pSRHS-EB and cultured for 36-48 h. Cells
were then resuspended by trypsinization, washed three
times, and stained for 1 h at RT with 5 μg/ml of the pri-
mary Ab. Cells stained with b12-Alexa
®647 or 902-Alex-
aFluor
®647 were washed three times prior to flow
cytometry analysis. Cells stained with 2G12 were washed
three times and then stained with the secondary Ab,
AlexaFluor
®647 Goat anti-human IgG (H+L), at 2 μg/ml
for 1 h at RT. Double-stained cells were washed three
times. Env surface expression was measured by flow
cytometry analysis utilizing the LSRII system and the
FACSDiva software (version 6.1), and analyzed using
FlowJo software (version 8.8.4). Samples for each mutant
were stained in triplicate, and a total of 50,000 events
were accumulated for each sample. For each of these
experiments, the mean fluorescence intensity (MFI) was
calculated and multiplied by the percent of the cell
population positive for both EBFP and R (660/20), to
produce the MFI Index [59].
Single-round infection
Single round infectivity was measured in a luciferase-based
virus-cell fusion assay. COS-1 cells were seeded at a den-
sity of 2.5 × 10
5 in 6-well plates and co-transfected with
the pSRHS expression vector and the pSG3Δenv proviral
vector. The pSG3Δenv proviral vector was used as a nega-
tive control. At 72 h posttransfection, viral supernatants
were clarified by centrifugation at 3,000 rpm for 20 min at
4°C to remove cellular debris. TZM-bl indicator cells (1 ×
10
5) seeded in 12-well plates were then infected with
equivalent amounts of virus (5 ng p24), which were nor-
malized by p24 enzyme-linked immunosorbent assay
(ELISA) [59,82]. Complete DMEM was added after a 2 h
incubation at 37°C, and luciferase activity was measured
48 h post infection as described above.
Multi-round replication of Env mutants on CEM (GXR25)
and H9 cells
Replicative capacity was assessed by infecting H9 and
CEM-GXR25 cells (kindly provided by Dr. Mark Brock-
man, Simon Frazier University). Virus stocks for replica-
tion assays were generated using the following method:
1 μg of proviral DNA was transfected into a 70% conflu-
ent monolayer of 293T cells using the Fugene HD trans-
fection reagent according to the manufacturer’s
protocol. Supernatants were collected 48 hrs post-trans-
fection, clarified by low speed centrifugation, and stored
at -80°C. The titer of each virus stock was determined
by infecting TZM-bl cells with 3-fold serial dilutions of
virus. Infectious units per μl( I U / μl) were determined
for each virus stock by counting blue foci in the infected
monolayers 48 hrs post-infection.
The day before replication assays, cells were split to 3
×1 0
5 cells/mL. 5 × 10
5 cells were infected at an MOI of
0.05 calculated based on the IU/μl determined by infec-
tion of TZM-bl cells. Cells were infected in a total
volume of 200 uL in a 96 well plate, using complete
RPMI and 5 μg/mL of Polybrene. Cells and virus were
incubated at 37°C for three hours, subsequently washed
4x to remove excess virus, and plated in 24-well plates
at a total volume of 1 mL. Culture supernatants were
collected and stored at -80°C on days 2, 4, 6, 8, 10 and
12 for viral quantification using a radiolabled reverse
transcriptase assay. Cells were split every two days and
replaced with fresh complete RPMI in order to maintain
cell confluency. GXR25 cells were split 1:2 while H9
cells were spit 2:3
Reverse transcriptase assay
Aliquots of culture supernatants from infected cells were
added to an RT-PCR master mix and incubated at 37
degrees for 2 hours; then the RT-PCR product was
blotted onto DE-81 paper, and allowed to dry. Blots were
w a s h e d5t i m e sw i t h1×S S C( 0 . 1 5MN a C l ,0 . 0 1 5M
sodium citrate, pH 7.0) and 3× with 90% ethanol, allowed
to dry, and exposed to a phophsoscreen overnight.
Counts were read using a Cyclone PhosphorImager.
Virus-cell fusion assay
A virion-based fusion assay was performed as previously
described by Cavrois [57-59]. BlaM-Vpr incorporated
NL4.3 viruses were produced by transient co-transfec-
tion of the proviral plasmid pNL4.3, the pCMV-BlaM-
Vpr vector (kindly provided by W. Greene, UCSF), and
the pAdvantage vector (Promega, Madison, WI) by
employing calcium phosphate precipitation of the DNA.
BlaM-Vpr incorporated viruses containing WT and
mutant Env glycoproteins were collected 48 h post-
transfection and filtered through a 0.45-μm membrane.
Viral supernatants were then loaded onto a 25% sucrose
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g for 2.5 h at 4°C as described above. The supernatant
and sucrose layers were then removed and the resulting
viral pellets were resuspended in serum-free DMEM.
The virus titers were normalized by p24 ELISAs, and
equivalent amounts of virus (200 ng p24) were then
added to TZM-bl cells (3 × 10
5), which were cultured in
CO2-independent medium (Gibco-BRL, Rockville, MD)
supplemented with 1% fetal bovine serum. The samples
were incubated at 37°C for 6 h, followed by removal of
free viruses with a wash in serum-free CO2-independent
medium. Because of a difference in temperature require-
ment, the fluorescent dye, CCF2-AM, was then loaded
into these cells by passive diffusion for 2 h at room tem-
perature, following the b-lactamase loading kit protocol
(Invitrogen, Carlsbad, CA). Following washing with
serum-free CO2-independent medium to remove any
residual extracellular dye, the cells were resuspended in
CO2-independent medium supplemented with 10% fetal
bovine serum and 2.5 mM probenecid. Subsequent to
incubation at room temperature in the dark for 16 h,
the cells were fixed with 4% paraformaldehyde at 4°C
for 20 min. The cells were then subjected to flow cyto-
metry analysis in a Beckman Dickinson LSRII cytometer.
Env incorporation into virions
293T cells (1 × 10
6) were transfected with proviral vec-
tors. Viral supernatants were harvested and clarified 72
h post transfection and were pelleted through a 25%
sucrose cushion by ultracentrifugation at 100, 000 × g
for 2.5 h. The layers of supernatant and sucrose were
carefully removed, and the resulting viral pellets were
resuspended in 200 μl PBS (pH 7.2). The viral pellets
were subjected to p24 ELISA, gp120 ELISA [59,82], and
gp41 western blot (using mAb Chessie 8 as the primary
Ab) to determine the amount of p24, gp120, and gp41.
Incorporation was determined by calculating the ratio of
gp120 and gp41 to p24.
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